# 바이오스페이스 일일 뉴스 리포트 - 2026년 01월 01일


## 주요 헤드라인

1. **Neurocrine’s Valbenazine Fails Phase III Neurodevelopmental Disorder Trial (#뉴스)**
   - Article content not available
   <https://www.biospace.com/drug-development/neurocrines-valbenazine-fails-phase-iii-neurodevelopmental-disorder-trial>

2. **Neurocrine’s Valbenazine Fails Phase III Neurodevelopmental Disorder Trial (#뉴스)**
   - Article content not available
   <https://www.biospace.com/drug-development/neurocrines-valbenazine-fails-phase-iii-neurodevelopmental-disorder-trial>

3. **Investment Banker Accused of Leaking Pharma M&A Secrets in $41M Insider Trading Scheme (#뉴스)**
   - Article content not available
   <https://www.biospace.com/business/investment-banker-accused-of-leaking-pharma-m-a-secrets-in-41m-insider-trading-scheme>

4. **Investment Banker Accused of Leaking Pharma M&A Secrets in $41M Insider Trading Scheme (#뉴스)**
   - Article content not available
   <https://www.biospace.com/business/investment-banker-accused-of-leaking-pharma-m-a-secrets-in-41m-insider-trading-scheme>

5. **Pfizer Reports Patient Death in Long-Term Trial of Hympavzi for Hemophilia A (#뉴스)**
   - Article content not available
   <https://www.biospace.com/drug-development/pfizer-reports-patient-death-in-long-term-trial-of-hympavzi-for-hemophilia-a>

6. **2025 (#뉴스)**
   - Article content not available
   <https://www.biospace.com/business/2025-the-year-trump-pushed-manufacturing-into-the-spotlight>

7. **ICYMI (#뉴스)**
   - Article content not available
   <https://www.biospace.com/business/icymi-5-biospace-features-from-2025-that-stand-the-test-of-time>


---
*2026년 01월 01일 바이오스페이스 뉴스 피드에서 생성된 리포트*